Aprogen aprogen.com


Aprogen is a Korean biopharmaceutical company established in April 2000 that develops and manufactures biosimilars and biologics with its proprietary protein engineering technologies, including a patented bispecific antibody-engineering platform. Aprogen’s proprietary cell-engineering technology, combined with an advanced perfusion cell culture technology, ensures an extremely high yield of protein production in mammalian cell culture; multiple folds greater than that of the industry average. ...Show all

Aprogen is a Korean biopharmaceutical company established in April 2000 that develops and manufactures biosimilars and biologics with its proprietary protein engineering technologies, including a patented bispecific antibody-engineering platform. Apr...Show all

Company (Alive / Active)

Phone: +82 31 625 4045

Fax:

545, Dunchon-daero
Jungwon-gu, Seongnam-si, Gyeonggi-do
Seongnam-Si, 13215
South Korea

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aprogen $62.1M May 31, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aprogen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-cd43 antibody and use thereof for cancer treatment Oct 12, 2016 Jun 09, 2020 Patent
Fusion proteins binding to vegf and angiopoietin Oct 31, 2007 Apr 16, 2019 Patent
Antibody binding to carbonic anhydrase and use thereof Nov 07, 2016 Apr 02, 2019 Patent
Recombinant expression vector for animal cell Jul 07, 2009 Apr 23, 2013 Patent
Humanized antibody and process for preparing same Mar 22, 2003 Apr 16, 2013 Patent
See all 15 patents